An HBV program built on ingenuity, vision and experience

goalOur goal is to discover and develop finite and curative therapies for those chronically infected with hepatitis B virus (HBV), and we believe we have unique capabilities that will enable us to bring the first therapeutic innovation in decades and improve cure rates for individuals with chronic HBV infection. Our strong scientific expertise in discovering small molecules
targeting the HBV core protein has made us a leader in the field.